tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Morning Movers: Under Armour sinks following second quarter earnings
PremiumThe FlyMorning Movers: Under Armour sinks following second quarter earnings
6d ago
ANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42
Premium
The Fly
ANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42
6d ago
ANI Pharmaceuticals raises FY25 adj. EPS view to $6.98-$7.35 from $6.27-$6.62
Premium
The Fly
ANI Pharmaceuticals raises FY25 adj. EPS view to $6.98-$7.35 from $6.27-$6.62
6d ago
Optimistic Growth Potential for ANI Pharmaceuticals Despite Challenges in DME Treatment
PremiumRatingsOptimistic Growth Potential for ANI Pharmaceuticals Despite Challenges in DME Treatment
20d ago
ANI Pharmaceuticals Reveals NEW DAY Study Results
Premium
Company Announcements
ANI Pharmaceuticals Reveals NEW DAY Study Results
22d ago
Optimistic Buy Rating for ANI Pharmaceuticals Despite Clinical Trial Challenges
Premium
Ratings
Optimistic Buy Rating for ANI Pharmaceuticals Despite Clinical Trial Challenges
22d ago
ANI Pharmaceuticals presents preclinical data on Purified Cortrophin Gel use
PremiumThe FlyANI Pharmaceuticals presents preclinical data on Purified Cortrophin Gel use
2M ago
ANI Pharmaceuticals Highlights Financial Performance Amid Challenges
Premium
Company Announcements
ANI Pharmaceuticals Highlights Financial Performance Amid Challenges
2M ago
ANI Pharmaceuticals Approves Key Proposals at Annual Meeting
Premium
Company Announcements
ANI Pharmaceuticals Approves Key Proposals at Annual Meeting
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100